THE COMPARATIVE PHARMACOKINETICS AND BIOEQUIVALENCE OF ROXITROMYCINS
The investigation has studied the pharmacokinetics and bioequivalence of the Russian medicine Brilid versus the similar drug Rulid registered in Russia. As the rate and completeness of roxitromycin absorption do not differ significantly when Brilid or Rulid is used, the above agents may be considered bioequivalent in terms of pharmacokinetic parameters.